Ginsenoside Rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma

Cellular Physiology and Biochemistry

Volumn 36, Issue 2, 2015, Pages 499-508

  Liu, Shunli ^a   Chen, Mingrui ^a   Li, Pengcheng ^b   Wu, Yujia ^b   Chang, Chunjuan ^b   Qiu, Yabin ^b   Cao, Ling ^b   Liu, Zhen ^b   Jia, Chiyu ^b  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Cancer stem cells (CSCs); Ginsenoside Rh2 (GRh2); Lgr5; Skin squamous cell carcinoma (SCC); catenin

Indexed keywords

AUTOPHAGY RELATED PROTEIN 7; BETA CATENIN; GINSENOSIDE RH 2; PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GINSENOSIDE; HERBACEOUS AGENT;

ARTICLE; AUTOPHAGY; CANCER INHIBITION; CANCER STEM CELL; CCK 8 ASSAY; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LENTIVIRINAE; MTT ASSAY; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN CARCINOMA; UPREGULATION; WESTERN BLOTTING; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; SKIN NEOPLASMS; TUMOR CELL LINE;

LENTIVIRUS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; GINSENOSIDES; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84929666847     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430115     Document Type: Article

References (44)

1. Rahimi S: Squamous cell carcinoma of skin: A brief review. Clin Ter 2013;164:143-147.
2. Winkelman C: Inactivity and inflammation: Selected cytokines as biologic mediators in muscle dysfunction during critical illness. AACN clinical issues 2004;15:74-82.
3. Ye H, Wu Q, Zhu Y, Guo C, Zheng X: Ginsenoside rh2 alleviates dextran sulfate sodium-induced colitis via augmenting tgfbeta signaling. Mol Biol Rep 2014;41:5485-5490.
4. Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T, Nagata I: Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside rh2 and adjuvant effects to cisplatin in vivo. Anticancer Drugs 1991;2:63-67.
5. Tode T, Kikuchi Y, Hirata J, Kita T, Imaizumi E, Nagata I: [inhibitory effects of oral administration of ginsenoside rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary]. Nihon Sanka Fujinka Gakkai zasshi 1993;45:1275-1282.
6. Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I: Inhibitory effects by oral administration of ginsenoside rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol 1993;120:24-26.
7. Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, Kudoh K, Nagata I, Shinomiya N: Inhibitory effects of ginsenoside rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 1998;89:733-740.
8. Tang XP, Tang GD, Fang CY, Liang ZH, Zhang LY: Effects of ginsenoside rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol 2013;19:1582-1592.
9. Liu J, Shimizu K, Yu H, Zhang C, Jin F, Kondo R: Stereospecificity of hydroxyl group at c-20 in antiproliferative action of ginsenoside rh2 on prostate cancer cells. Fitoterapia 2010;81:902-905.
10. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W: Ginsenoside rh2 induces apoptosis and paraptosislike cell death in colorectal cancer cells through activation of p53. Cancer Lett 2011;301:185-192.
11. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND: Anti-proliferating effects of ginsenoside rh2 on mcf-7 human breast cancer cells. Int J Oncol 1999;14:869-875.
12. Choi S, Kim TW, Singh SV: Ginsenoside rh2-mediated g1 phase cell cycle arrest in human breast cancer cells is caused by p15 ink4b and p27 kip1-dependent inhibition of cyclin-dependent kinases. Pharm Res 2009;26:2280-2288.
13. Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T, Liu Y: Egfr signaling-dependent inhibition of glioblastoma growth by ginsenoside rh2. Tumour Biol 2014;35:5593-5598.
14. Xu J, Fan W, Tu XX, Zhang T, Hou ZJ, Guo T, Shu X, Luo X, Liu Y, Peng F, Wang C, Xu L, Zhou H, Liu Q: Neural ganglioside gd2(+) cells define a subpopulation of mesenchymal stem cells in adult murine bone marrow. Cell Physiol Biochem 2013;32:889-898.
15. Petersson M, Niemann C: Stem cell dynamics and heterogeneity: Implications for epidermal regeneration and skin cancer. Curr Med Chem 2012;19:5984-5992.
16. Perez-Losada J, Balmain A: Stem-cell hierarchy in skin cancer. Nat Rev Cancer 2003;3:434-443.
17. Chen Q, Cai ZK, Chen YB, Gu M, Zheng DC, Zhou J, Wang Z: Poly r(c) binding protein-1 is central to maintenance of cancer stem cells in prostate cancer cells. Cell Physiol Biochem 2015;35:1052-1061.
18. He QZ, Luo XZ, Wang K, Zhou Q, Ao H, Yang Y, Li SX, Li Y, Zhu HT, Duan T: Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas. Cell Physiol Biochem 2014;33:173-184.
19. Nagata T, Sakakura C, Komiyama S, Miyashita A, Nishio M, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E: Expression of cancer stem cell markers cd133 and cd44 in locoregional recurrence of rectal cancer. Anticancer Res 2011;31:495-500.
20. Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, Moore PA: Expansion of cd133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 2010;102:1265-1275.
21. Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, Li X, He Z, Gong W, Qin R: Cd44+ cd133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol Ther 2010;10:1182-1190.
22. Ottaiano A: Finding markers for cancer stem cells in renal cell carcinoma: Looking beyond cd133. Cell Cycle 2010;9:4431.
23. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY: Aldehyde dehydrogenase discriminates the cd133 liver cancer stem cell populations. Mol Cancer Res 2008;6:1146-1153.
24. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, Svendsen A, Prestegarden L, Rosland G, Thorsen F, Stuhr L, Molven A, Bjerkvig R, Enger PO: Cd133 negative glioma cells form tumors in nude rats and give rise to cd133 positive cells. Int J Cancer 2008;122:761-768.
25. Takubo K, Ohmura M, Azuma M, Nagamatsu G, Yamada W, Arai F, Hirao A, Suda T: Stem cell defects in atmdeficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest. Cell Stem Cell 2008;2:170-182.
26. Duester G: Families of retinoid dehydrogenases regulating vitamin a function: Production of visual pigment and retinoic acid. Eur J Biochem 2000;267:4315-4324.
27. Magni M, Shammah S, Schiro R, Mellado W, Dalla-Favera R, Gianni AM: Induction of cyclophosphamideresistance by aldehyde-dehydrogenase gene transfer. Blood 1996;87:1097-1103.
28. Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ: Aldehyde dehydrogenase in combination with cd133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 2011;71:3991-4001.
29. Ma I, Allan AL: The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2011;7:292-306.
30. Liu Y, Jiang X, Zeng Y, Zhou H, Yang J, Cao R: Proliferating pancreatic beta-cells upregulate aldh. Histochem Cell Biol 2014;142:685-691.
31. Zhang L, Wang L, Liu X, Zheng D, Liu S, Liu C: Aldh expression characterizes g1-phase proliferating beta cells during pregnancy. PLoS One 2014;9:e96204.
32. Kinzel B, Pikiolek M, Orsini V, Sprunger J, Isken A, Zietzling S, Desplanches M, Dubost V, Breustedt D, Valdez R, Liu D, Theil D, Muller M, Dietrich B, Bouwmeester T, Ruffner H, Tchorz JS: Functional roles of lgr4 and lgr5 in embryonic gut, kidney and skin development in mice. Dev Biol 2014;390:181-190.
33. Haegebarth A, Clevers H: Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 2009;174:715-721.
34. Liu S, Gong Z, Chen M, Liu B, Bian D, Wu K: Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma. Tumour Biol 2014;35:11605-11612.
35. Yin YC, Lin CC, Chen TT, Chen JY, Tsai HJ, Wang CY, Chen SY: Clozapine induces autophagic cell death in nonsmall cell lung cancer cells. Cell Physiol Biochem 2015;35:945-956.
36. Zhao M, Sun L, Yu XJ, Miao Y, Liu JJ, Wang H, Ren J, Zang WJ: Acetylcholine mediates ampk-dependent autophagic cytoprotection in h9c2 cells during hypoxia/reoxygenation injury. Cell Physiol Biochem 2013;32:601-613.
37. Wei YM, Li X, Xu M, Abais JM, Chen Y, Riebling CR, Boini KM, Li PL, Zhang Y: Enhancement of autophagy by simvastatin through inhibition of rac1-mtor signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 2013;31:925-937.
38. Lin R, Feng J, Dong S, Pan R, Zhuang H, Ding Z: Regulation of autophagy of prostate cancer cells by betacatenin signaling. Cell Physiol Biochem 2015;35:926-932.
39. Kim W, Kim M, Jho EH: Wnt/beta-catenin signalling: From plasma membrane to nucleus. Biochem J 2013;450:9-21.
40. Gewirtz DA: Autophagy and senescence in cancer therapy. J Cell Physiol 2014;229:6-9.
41. Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T, Fu W, Zhang J, Wu W, Zhang X, Chen YG: Autophagy negatively regulates wnt signalling by promoting dishevelled degradation. Nat Cell Biol 2010;12:781-790.
42. Zhang Y, Wang F, Han L, Wu Y, Li S, Yang X, Wang Y, Ren F, Zhai Y, Wang D, Jia B, Xia Y, Chang Z: Gabarapl1 negatively regulates wnt/beta-catenin signaling by mediating dvl2 degradation through the autophagy pathway. Cell Physiol Biochem 2011;27:503-512.
43. Cicchini M, Chakrabarti R, Kongara S, Price S, Nahar R, Lozy F, Zhong H, Vazquez A, Kang Y, Karantza V: Autophagy regulator becn1 suppresses mammary tumorigenesis driven by wnt1 activation and following parity. Autophagy 2014;10:2036-2052.
44. Holla S, Kurowska-Stolarska M, Bayry J, Balaji KN: Selective inhibition of ifng-induced autophagy by mir155-and mir31-responsive wnt5a and shh signaling. Autophagy 2014;10:311-330.